Polaris AI Pharma Corp. (KOSDAQ: A041910)
Health Care · Pharmaceuticals · KR
₩5,150.00
-6.70% today · -18.5% 1Y
Polaris AI Pharma Corp. (KOSDAQ: A041910) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $49.36M.
Over the last twelve months the share price has lost 18.5%, trading between 4.11K and 10.20K.
Tweenvest scores Polaris AI Pharma Corp. across four factors: quality 70/100, value 56/100, growth 29/100. Its strongest factor is quality.
A041910 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $49.36M
- Revenue (TTM)
- $44.52M
- P/E
- 60.79
- EPS
- 84.72
- Dividend yield
- —
- Beta (5Y)
- 0.44
- 52-week high
- ₩10,200.00
- 52-week low
- ₩4,110.00
- Avg volume (3M)
- —
- Shares outstanding
- 13.28M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,211.05 | -1.83% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $271.68 | -0.53% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $154.97 | -0.95% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.20 | -1.50% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.46 | -1.84% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.29 | -1.00% |
Figures last refreshed Aug 18, 2026.